MDDAX
Price
$9.71
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
324.7M
VVIAX
Price
$66.85
Change
-$0.13 (-0.19%)
Updated
Jun 5 closing price
Net Assets
188.77B
Interact to see
Advertisement

MDDAX vs VVIAX

Header iconMDDAX vs VVIAX Comparison
Open Charts MDDAX vs VVIAXBanner chart's image
MassMutual Diversified Value A
Price$9.71
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets324.7M
Vanguard Value Index Adm
Price$66.85
Change-$0.13 (-0.19%)
VolumeN/A
Net Assets188.77B
MDDAX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDDAX vs. VVIAX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDDAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. MDDAX (325M). VVIAX pays higher dividends than MDDAX: VVIAX (2.28) vs MDDAX (1.40). MDDAX was incepted earlier than VVIAX: MDDAX (21 years) vs VVIAX (25 years). MDDAX (1.14) is less costly to investors than VVIAX (0.05). MDDAX is a more actively managed with annual turnover of: 46.00 vs. VVIAX (9.00). MDDAX has a lower initial minimum investment than VVIAX: MDDAX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 6.91 vs. MDDAX (-20.46). VVIAX return over 5 years is better than : 59.00 vs. MDDAX (1.63).
MDDAXVVIAXMDDAX / VVIAX
Total Expense Ratio1.140.052,280%
Annual Report Gross Expense Ratio1.140.052,280%
Fund Existence21 years25 years-
Gain YTD1.5691.452108%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets325M189B0%
Annual Yield % from dividends1.402.2862%
Returns for 1 year-20.466.91-296%
Returns for 3 years-19.1420.08-95%
Returns for 5 years1.6359.003%
Returns for 10 years-24.31103.66-23%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EXHAX25.75N/A
N/A
Manning & Napier Pro-Blend Max Term S
PCAOX79.35N/A
N/A
Principal Capital Appreciation R3
JEMGX10.00N/A
N/A
JHancock Emerging Markets Equity R6
FWMNX17.07N/A
N/A
Fidelity Advisor Women's Leadership I
NSFBX8.76-0.01
-0.11%
Natixis Target Retirement 2015 N